Human T-lymphotropic virus 1
(Redirected from Human T-lymphotropic virus 1 infection)
Human T-lymphotropic virus 1 (HTLV-1) is a retrovirus that infects T-lymphocytes, a type of white blood cell that plays a central role in the immune system. HTLV-1 is associated with several diseases, including adult T-cell leukemia/lymphoma (ATLL) and HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Virology[edit | edit source]
HTLV-1 is a member of the Deltaretrovirus genus within the Retroviridae family. The virus has a single-stranded RNA genome that is reverse transcribed into DNA and integrated into the host cell's genome. The viral genome encodes several proteins, including gag, pol, and env, which are essential for viral replication and assembly.
Transmission[edit | edit source]
HTLV-1 is transmitted through several routes:
- Mother-to-child transmission (primarily through breastfeeding)
- Sexual transmission
- Blood transfusion
- Intravenous drug use
Epidemiology[edit | edit source]
HTLV-1 is endemic in certain regions, including Japan, the Caribbean, parts of Africa, and South America. The prevalence of HTLV-1 infection varies widely, with some areas having infection rates as high as 10%.
Clinical Manifestations[edit | edit source]
HTLV-1 infection can lead to several clinical conditions:
- Adult T-cell leukemia/lymphoma (ATLL): A rare and aggressive form of cancer that affects T-lymphocytes.
- HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A chronic and progressive disease of the spinal cord.
- Infective dermatitis: A chronic skin condition seen primarily in children.
Diagnosis[edit | edit source]
Diagnosis of HTLV-1 infection is typically made through serological testing to detect antibodies against the virus. Polymerase chain reaction (PCR) can also be used to detect viral DNA in infected cells.
Treatment[edit | edit source]
There is currently no cure for HTLV-1 infection. Treatment focuses on managing symptoms and complications. Antiretroviral therapy has limited efficacy in HTLV-1 infection, and treatment for ATLL may include chemotherapy and antiviral drugs.
Prevention[edit | edit source]
Preventive measures include:
- Screening of blood products for HTLV-1
- Encouraging safe sex practices
- Avoiding breastfeeding by HTLV-1 infected mothers
See Also[edit | edit source]
- Retrovirus
- Adult T-cell leukemia/lymphoma
- HTLV-1 associated myelopathy/tropical spastic paraparesis
- Infective dermatitis
- Serological testing
- Polymerase chain reaction
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD